C1q and central nervous system disorders

被引:22
|
作者
Zhang, Wenjie [1 ,2 ]
Chen, Yuan [3 ]
Pei, Hui [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Emergency, Intens Care Unit, Zhengzhou, Peoples R China
[2] Xingyang Sishui Cent Hlth Ctr, Dept Gen Practice, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
关键词
c1q; central nervous system; neurodevelopment; degenerative diseases; inflammatory diseases; glioma; GUILLAIN-BARRE-SYNDROME; TRAUMATIC BRAIN-INJURY; COMPLEMENT PROTEIN C1Q; MOUSE MODEL; SPINAL-CORD; COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; PATHWAY ACTIVATION; CLASSICAL PATHWAY; UP-REGULATION;
D O I
10.3389/fimmu.2023.1145649
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
C1q is a crucial component of the complement system, which is activated through the classical pathway to perform non-specific immune functions, serving as the first line of defense against pathogens. C1q can also bind to specific receptors to carry out immune and other functions, playing a vital role in maintaining immune homeostasis and normal physiological functions. In the developing central nervous system (CNS), C1q functions in synapse formation and pruning, serving as a key player in the development and homeostasis of neuronal networks in the CNS. C1q has a close relationship with microglia and astrocytes, and under their influence, C1q may contribute to the development of CNS disorders. Furthermore, C1q can also have independent effects on neurological disorders, producing either beneficial or detrimental outcomes. Most of the evidence for these functions comes from animal models, with some also from human specimen studies. C1q is now emerging as a promising target for the treatment of a variety of diseases, and clinical trials are already underway for CNS disorders. This article highlights the role of C1q in CNS diseases, offering new directions for the diagnosis and treatment of these conditions.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Therapeutic potential of fucoidan in central nervous system disorders: A systematic review
    Yang, Jing
    Zhao, He
    Qu, Shengtao
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 277
  • [42] Neuronopathic lysosomal storage disorders: Approaches to treat the central nervous system
    Scarpa, Maurizio
    Bellettato, Cinzia Maria
    Lampe, Christina
    Leader, Deputy
    Begley, David J.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 29 (02) : 159 - 171
  • [43] Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders
    Peng, Shasha
    Liu, Jiachen
    Liang, Chuntian
    Yang, Lijun
    Wang, Gaiqing
    NEUROBIOLOGY OF DISEASE, 2023, 179
  • [44] Autoantibody-mediated disorders of the central nervous system
    Irani, Sarosh
    Lang, Bethan
    AUTOIMMUNITY, 2008, 41 (01) : 55 - 65
  • [45] Treatment of central nervous system manifestations in mitochondrial disorders
    Finsterer, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (01) : 28 - 38
  • [46] Central nervous system
    Adamson, D. Cory
    Rasheed, B. Ahmed K.
    McLendon, Roger E.
    Bigner, Darell D.
    CANCER BIOMARKERS, 2011, 9 (1-6) : 193 - 210
  • [47] Targeting protein kinases in central nervous system disorders
    Chico, Laura K.
    Van Eldik, Linda J.
    Watterson, D. Martin
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (11) : 892 - 909
  • [48] Language disorders in children with central nervous system injury
    Dennis, Maureen
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2010, 32 (04) : 417 - 432
  • [49] CELL TRANSPLANTATION FOR CENTRAL-NERVOUS-SYSTEM DISORDERS
    KOUTOUZIS, TK
    EMERICH, DF
    BORLONGAN, CV
    FREEMAN, TB
    CAHILL, DW
    SANBERG, PR
    CRITICAL REVIEWS IN NEUROBIOLOGY, 1994, 8 (03): : 125 - 162
  • [50] Beneficial Effects of Capsaicin in Disorders of the Central Nervous System
    Pasierski, Michal
    Szulczyk, Bartlomiej
    MOLECULES, 2022, 27 (08):